Microbot Medical Inc (MBOT) has a current Price-to-Book (P/B) ratio of 1.78. Compared to its 3-year average P/B ratio of 3.50, the current P/B ratio is approximately -49.27% higher. Relative to its 5-year average P/B ratio of 3.43, the current P/B ratio is about -48.25% higher. Microbot Medical Inc (MBOT) has a Forward Free Cash Flow (FCF) yield of approximately -7.78%. Compared to its 3-year average FCF yield of -40.07%, the current FCF yield is approximately -80.59% lower. Relative to its 5-year average FCF yield of -33.79%, the current FCF yield is about -76.98% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for MBOT competitors is 12.62, providing a benchmark for relative valuation. Microbot Medical Inc Corp (MBOT.O) exhibits a P/S ratio of 55.41, which is 338.97% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of MBOT increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of MBOT in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is MBOT currently overvalued or undervalued?

What is Microbot Medical Inc (MBOT) fair value?

MBOT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Microbot Medical Inc (MBOT) is between to according to relative valuation method.

How does MBOT's valuation metrics compare to the industry average?

The average P/S ratio for MBOT's competitors is 12.62, providing a benchmark for relative valuation. Microbot Medical Inc Corp (MBOT) exhibits a P/S ratio of 55.41, which is 338.97% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

What is the current P/B ratio for Microbot Medical Inc (MBOT) as of Mar 03 2026?

As of Mar 03 2026, Microbot Medical Inc (MBOT) has a P/B ratio of 1.78. This indicates that the market values MBOT at 1.78 times its book value.

What is the current FCF Yield for Microbot Medical Inc (MBOT) as of Mar 03 2026?

As of Mar 03 2026, Microbot Medical Inc (MBOT) has a FCF Yield of -7.78%. This means that for every dollar of Microbot Medical Inc's market capitalization, the company generates -7.78 cents in free cash flow.

What is the current Forward P/E ratio for Microbot Medical Inc (MBOT) as of Mar 03 2026?

As of Mar 03 2026, Microbot Medical Inc (MBOT) has a Forward P/E ratio of -6.59. This means the market is willing to pay $-6.59 for every dollar of Microbot Medical Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Microbot Medical Inc (MBOT) as of Mar 03 2026?

As of Mar 03 2026, Microbot Medical Inc (MBOT) has a Forward P/S ratio of 55.41. This means the market is valuing MBOT at $55.41 for every dollar of expected revenue over the next 12 months.

MBOT Valuation